Janine M. Lupo, Ph.D. - Publications

Affiliations: 
2006 University of California, San Francisco, San Francisco, CA 
Area:
Molecular Biology of Transcription Circuit Evolution, Candida albicans pathogenesis

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ellison J, Caliva F, Damasceno P, Luks TL, LaFontaine M, Cluceru J, Kemisetti A, Li Y, Molinaro AM, Pedoia V, Villanueva-Meyer JE, Lupo JM. Improving the Generalizability of Deep Learning for T2-Lesion Segmentation of Gliomas in the Post-Treatment Setting. Bioengineering (Basel, Switzerland). 11. PMID 38790363 DOI: 10.3390/bioengineering11050497  0.302
2022 Avalos LN, Luks TL, Gleason T, Damasceno P, Li Y, Lupo JM, Phillips J, Oberheim Bush NA, Taylor JW, Chang SM, Villanueva-Meyer JE. Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase. Neuro-Oncology Advances. 4: vdac175. PMID 36479058 DOI: 10.1093/noajnl/vdac175  0.379
2021 Morrison MA, Lupo JM. 7-T Magnetic Resonance Imaging in the Management of Brain Tumors. Magnetic Resonance Imaging Clinics of North America. 29: 83-102. PMID 33237018 DOI: 10.1016/j.mric.2020.09.007  0.305
2020 Morrison MA, Mueller S, Felton E, Jakary A, Stoller S, Avadiappan S, Yuan J, Molinaro AM, Braunstein S, Banerjee A, Hess CP, Lupo JM. Rate of radiation-induced microbleed formation on 7T MRI relates to cognitive impairment in young patients treated with radiation therapy for a brain tumor. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32966846 DOI: 10.1016/J.Radonc.2020.09.028  0.406
2020 Han M, Yang B, Fernandez B, Lafontaine M, Alcaide-Leon P, Jakary A, Burns BL, Morrison MA, Villanueva-Meyer JE, Chang SM, Banerjee S, Lupo JM. Simultaneous multi-slice spin- and gradient-echo dynamic susceptibility-contrast perfusion-weighted MRI of gliomas. Nmr in Biomedicine. e4399. PMID 32844496 DOI: 10.1002/Nbm.4399  0.43
2020 Autry AW, Gordon JW, Chen HY, LaFontaine M, Bok R, Van Criekinge M, Slater JB, Carvajal L, Villanueva-Meyer JE, Chang SM, Clarke JL, Lupo JM, Xu D, Larson PEZ, Vigneron DB, et al. Characterization of serial hyperpolarized C metabolic imaging in patients with glioma. Neuroimage. Clinical. 27: 102323. PMID 32623139 DOI: 10.1016/J.Nicl.2020.102323  0.435
2020 Avadiappan S, Payabvash S, Morrison MA, Jakary A, Hess CP, Lupo JM. A Fully Automated Method for Segmenting Arteries and Quantifying Vessel Radii on Magnetic Resonance Angiography Images of Varying Projection Thickness. Frontiers in Neuroscience. 14: 537. PMID 32612496 DOI: 10.3389/Fnins.2020.00537  0.317
2020 Cluceru J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P, Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, ... Lupo JM, et al. Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas. Neuro-Oncology. PMID 32319527 DOI: 10.1093/Neuonc/Noaa094  0.371
2019 Alcaide-Leon P, Luks TL, Lafontaine M, Lupo JM, Okada H, Clarke JL, Villanueva-Meyer JE. Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy. Journal of Neuro-Oncology. PMID 31728884 DOI: 10.1007/S11060-019-03336-3  0.348
2019 Morrison MA, Hess CP, Clarke JL, Butowski N, Chang SM, Molinaro AM, Lupo JM. Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors. Journal of Magnetic Resonance Imaging : Jmri. PMID 30663150 DOI: 10.1002/Jmri.26651  0.413
2019 Morrison M, Avadiappan S, Yuan J, Stoller S, Jakary A, Mueller S, Molinaro A, Banerjee A, Hess C, Braunstein S, Lupo J. NIMG-56. A MULTIMODAL 7 TELSA MRI INVESTIGATION OF LONG-TERM EFFECTS OF RADIOTHERAPY ON THE ADOLESCENT BRAIN & COGNITION Neuro-Oncology. 21: vi173-vi174. DOI: 10.1093/Neuonc/Noz175.725  0.424
2019 Alcaide-Leon P, Cluceru J, Luks T, Lupo J, Villanueva-Meyer J. NIMG-51. THE CENTRALLY RESTRICTED DIFFUSION SIGN FOR DIFFERENTIATION BETWEEN TREATMENT-RELATED LESIONS AND TUMOR PROGRESSION IN GLIOMA PATIENTS: A VALIDATION STUDY Neuro-Oncology. 21: vi172-vi172. DOI: 10.1093/Neuonc/Noz175.720  0.38
2019 Liu J, Jakary A, Lafontaine M, Wang Y, Xu D, Saloner D, Butowski N, Hess C, Villanueva-Meyer J, Chang S, Lupo J. NIMG-45. 3D SINGLE-SCAN FOR MULTI-CONTRAST-WEIGHTED MRI FOR LESION DETECTION IN PATIENTS WITH GLIOMAS Neuro-Oncology. 21: vi171-vi171. DOI: 10.1093/Neuonc/Noz175.715  0.452
2019 Avadiappan S, Morrison M, Jakary A, Felton E, Stoller S, Hess C, Mueller S, Braunstein S, Lupo J. MEDU-43. GLOBAL AND REGIONAL EFFECTS OF RADIATION THERAPY ON CEREBRAL MICROVASCULATURE IN PEDIATRIC BRAIN TUMOR SURVIVORS Neuro-Oncology. 21: ii112-ii112. DOI: 10.1093/Neuonc/Noz036.201  0.386
2019 Morrison M, Jakary A, Felton E, Stoller S, Yuan J, Mueller S, Lupo J. MEDU-18. FUNCTIONAL BRAIN NETWORK PROPERTIES AND COGNITIVE IMPAIRMENT IN ADOLESCENTS FOLLOWING RADIATION THERAPY Neuro-Oncology. 21: ii107-ii107. DOI: 10.1093/Neuonc/Noz036.177  0.308
2019 Yuan J, Morrison M, Jakary A, Mueller S, Tymofiyeva O, Xu D, Lupo J. MEDU-15. STRUCTURAL BRAIN NETWORK PROPERTIES AND COGNITIVE IMPAIRMENT IN ADOLESCENTS AFTER RADIATION THERAPY Neuro-Oncology. 21: ii106-ii106. DOI: 10.1093/Neuonc/Noz036.174  0.305
2019 Autry A, Park I, Chen H, Gordon J, Kline-Nunnally C, Vigneron D, Lupo J, Li Y, Xu D, Mueller S. DIPG-31. FEASIBILITY OF HYPERPOLARIZED 13C METABOLIC IMAGING IN PEDIATRIC PATIENTS WITH DIPG AND OTHER CNS CANCERS Neuro-Oncology. 21: ii75-ii75. DOI: 10.1093/Neuonc/Noz036.052  0.352
2018 Chen Y, Villanueva-Meyer JE, Morrison MA, Lupo JM. Toward Automatic Detection of Radiation-Induced Cerebral Microbleeds Using a 3D Deep Residual Network. Journal of Digital Imaging. PMID 30511280 DOI: 10.1007/S10278-018-0146-Z  0.363
2018 Park I, Lupo JM, Nelson SJ. Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 30225760 DOI: 10.1007/S11307-018-1275-Y  0.412
2018 Vareth M, Lupo J, Larson P, Nelson S. A comparison of coil combination strategies in 3D multi-channel MRSI reconstruction for patients with brain tumors. Nmr in Biomedicine. e3929. PMID 30168205 DOI: 10.1002/Nbm.3929  0.333
2018 Avadiappan S, Morrison M, Jakary A, Felton E, Mueller S, Lupo J. RTHP-21. CHARACTERIZATION OF RADIATION THERAPY EFFECTS ON CEREBRAL VASCULATURE IN PEDIATRIC BRAIN TUMOR SURVIVORS Neuro-Oncology. 20: vi229-vi229. DOI: 10.1093/Neuonc/Noy148.951  0.394
2018 Cluceru J, Nelson S, Molinaro A, Phillips JJ, Olson B, Lafontaine M, Jakary A, Nair D, Chang S, Alcaide-Leon P, Berger M, Lupo J. NIMG-11. DIFFERENTIATING TREATMENT-INDUCED EFFECTS FROM TRUE RECURRENT HIGH GRADE GLIOMA USING MULTIPARAMETRIC MRI TECHNIQUES Neuro-Oncology. 20: vi177-vi178. DOI: 10.1093/Neuonc/Noy148.738  0.333
2017 Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Translational Oncology. 10: 895-903. PMID 28942218 DOI: 10.1016/J.Tranon.2017.08.009  0.434
2017 Wahl M, Anwar M, Hess CP, Chang SM, Lupo JM. Relationship between radiation dose and microbleed formation in patients with malignant glioma. Radiation Oncology (London, England). 12: 126. PMID 28797254 DOI: 10.1186/S13014-017-0861-5  0.353
2017 Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiation Research. PMID 28723274 DOI: 10.1667/Rr14662.1  0.456
2017 Zou X, Hart BL, Mabray M, Bartlett MR, Bian W, Nelson J, Morrison LA, McCulloch CE, Hess CP, Lupo JM, Kim H. Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations. Neuroradiology. PMID 28534135 DOI: 10.1007/S00234-017-1845-8  0.537
2017 Morrison M, Jakary A, Bian W, Wen Q, Hess C, Clarke J, Butowski N, Chang S, Nelson S, Lupo J. RTHP-02. CHARACTERIZATION AND EVOLUTION OF RADIOTHERAPY-INDUCED VASCULAR INJURY AND CORRESPONDING CHANGES IN WHITE MATTER STRUCTURE: AN INVESTIGATIVE STUDY IN 125 PATIENTS WITH GLIOMAS Neuro-Oncology. 19: vi219-vi219. DOI: 10.1093/Neuonc/Nox168.887  0.518
2017 Jakary A, Hess C, LaFontaine M, Larson P, Butowski N, Clarke J, Chang S, Lupo J. NIMG-64. THE POTENTIAL OF 7T ANATOMICAL IMAGING FOR CLINICAL ASSESSMENT OF CONTRAST-ENHANCING AND T2-HYPERINTENSE LESIONS IN PATIENTS WITH GLIOMA Neuro-Oncology. 19: vi156-vi156. DOI: 10.1093/Neuonc/Nox168.637  0.377
2017 Morin O, Wahl M, Jordan K, Lupo J, Anwar M, Braunstein S. Application of Diffusion Weighted MRI for Target Delineation in Radiation Therapy for Glioblastoma International Journal of Radiation Oncology*Biology*Physics. 99: E96. DOI: 10.1016/J.Ijrobp.2017.06.819  0.392
2016 Roddy E, Sear K, Felton E, Tamrazi B, Gauvain K, Torkildson J, Buono BD, Samuel D, Haas-Kogan DA, Chen J, Goldsby RE, Banerjee A, Lupo JM, Molinaro AM, Fullerton HJ, et al. Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro-Oncology. PMID 27540084 DOI: 10.1093/Neuonc/Now163  0.308
2016 Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. Journal of Neuro-Oncology. PMID 27535746 DOI: 10.1007/S11060-016-2229-3  0.504
2016 Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro-Oncology. PMID 26911151 DOI: 10.1093/Neuonc/Now008  0.375
2016 Park I, von Morze C, Lupo JM, Ardenkjaer-Larsen JH, Kadambi A, Vigneron DB, Nelson SJ. Investigating tumor perfusion by hyperpolarized (13) C MRI with comparison to conventional gadolinium contrast-enhanced MRI and pathology in orthotopic human GBM xenografts. Magnetic Resonance in Medicine. PMID 26892398 DOI: 10.1002/Mrm.26155  0.397
2016 Parvathaneni P, Phillips J, Cabrera JR, Shai A, Cha S, Chang S, Nelson S, Lupo J. NIMG-43. APPLICATION OF AN ADVANCED DIFFUSION-WEIGHTED MRI TECHNIQUE TO CHARACTERIZE GLIOMA MICROSTRUCTURE AND RELATIONSHIP TO HISTOPATHOLOGY Neuro-Oncology. 18: vi134-vi134. DOI: 10.1093/Neuonc/Now212.555  0.327
2016 Roddy E, Sear K, Felton E, Tamrazi B, Gauvain K, Torkildson J, Del Buono B, Samuel D, Haas-Kogan D, Chen J, Goldsby R, Banerjee A, Lupo J, Molinaro A, Fullerton H, et al. RO-02CEREBRAL MICROBLEEDS ARE ASSOCIATED WITH WORSE EXECUTIVE FUNCTION IN PEDIATRIC BRAIN TUMOR SURVIVORS Neuro-Oncology. 18: iii159.2-iii159. DOI: 10.1093/Neuonc/Now082.02  0.302
2015 Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ. Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials. Translational Oncology. 8: 446-55. PMID 26692525 DOI: 10.1016/J.Tranon.2015.10.001  0.455
2015 Chaumeil MM, Lupo JM, Ronen SM. Magnetic Resonance (MR) Metabolic Imaging in Glioma. Brain Pathology (Zurich, Switzerland). 25: 769-80. PMID 26526945 DOI: 10.1111/Bpa.12310  0.415
2015 Wen Q, Kelley DA, Banerjee S, Lupo JM, Chang SM, Xu D, Hess CP, Nelson SJ. Clinically feasible NODDI characterization of glioma using multiband EPI at 7 T. Neuroimage. Clinical. 9: 291-9. PMID 26509116 DOI: 10.1016/J.Nicl.2015.08.017  0.368
2015 Lupo JM, Molinaro AM, Essock-Burns E, Butowski N, Chang SM, Cha S, Nelson SJ. The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma†. Neuro-Oncology. PMID 26206774 DOI: 10.1093/Neuonc/Nov128  0.752
2015 Bian W, Banerjee S, Kelly DA, Hess CP, Larson PE, Chang SM, Nelson SJ, Lupo JM. Simultaneous imaging of radiation-induced cerebral microbleeds, arteries and veins, using a multiple gradient echo sequence at 7 Tesla. Journal of Magnetic Resonance Imaging : Jmri. 42: 269-79. PMID 25471321 DOI: 10.1002/Jmri.24802  0.566
2015 Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. Journal of Neuro-Oncology. 121: 331-9. PMID 25351579 DOI: 10.1007/S11060-014-1636-6  0.469
2015 Li Y, Larson P, Chen AP, Lupo JM, Ozhinsky E, Kelley D, Chang SM, Nelson SJ. Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels. Journal of Magnetic Resonance Imaging : Jmri. 41: 1332-41. PMID 24935758 DOI: 10.1002/Jmri.24672  0.716
2014 Lupo JM, Nelson SJ. Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma. Seminars in Radiation Oncology. 24: 248-58. PMID 25219809 DOI: 10.1016/J.Semradonc.2014.06.008  0.515
2014 Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM. Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T. Neuroradiology. 56: 91-6. PMID 24281386 DOI: 10.1007/S00234-013-1297-8  0.604
2014 Vaziri S, Lafontaine M, Olson B, Crane JC, Chang S, Lupo J, Nelson SJ. NI-79 * RAPID ASSESSMENT OF LESION VOLUMES FOR PATIENTS WITH GLIOMA USING THE SMARTBRUSH SOFTWARE PACKAGE Neuro-Oncology. 16: v156-v156. DOI: 10.1093/Neuonc/Nou264.77  0.407
2014 Anwar M, Lupo J, Molinaro A, Chang S, Nelson S, Haas-Kogan D. Determining Voxel Response to Radiation Therapy in Glioblastoma Using Integrated Dosimetry, Diffusion, Perfusion, and Spectra International Journal of Radiation Oncology*Biology*Physics. 90: S291. DOI: 10.1016/J.Ijrobp.2014.05.984  0.385
2013 Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM. Computer-aided detection of radiation-induced cerebral microbleeds on susceptibility-weighted MR images. Neuroimage. Clinical. 2: 282-90. PMID 24179783 DOI: 10.1016/J.Nicl.2013.01.012  0.578
2013 Lupo JM, Essock-Burns E, Molinaro AM, Cha S, Chang SM, Butowski N, Nelson SJ. Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme. Neuro-Oncology. 15: 480-9. PMID 23393208 DOI: 10.1093/Neuonc/Nos325  0.76
2013 Li Y, Lupo JM, Parvataneni R, Lamborn KR, Cha S, Chang SM, Nelson SJ. Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. Neuro-Oncology. 15: 607-17. PMID 23393206 DOI: 10.1093/Neuonc/Nos334  0.474
2013 Essock-Burns E, Phillips JJ, Molinaro AM, Lupo JM, Cha S, Chang SM, Nelson SJ. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM. Journal of Magnetic Resonance Imaging : Jmri. 38: 388-400. PMID 23281184 DOI: 10.1002/Jmri.23982  0.745
2013 Bian W, Harter K, Hammond-Rosenbluth KE, Lupo JM, Xu D, Kelley DA, Vigneron DB, Nelson SJ, Pelletier D. A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 69-75. PMID 22641301 DOI: 10.1177/1352458512447870  0.544
2013 Blakeley JO, Fisher JD, Lieberman FS, Lupo J, Nabors LB, Crane J, Wen PY, Cote A, Peereboom DM, Wen Q, Cloughesy TF, Robins HI, Desideri S, Grossman SA, Ye X, et al. Imaging biomarkers of ramucirumab and olaratumab in patients with recurrent glioblastoma. Journal of Clinical Oncology. 31: 2044-2044. DOI: 10.1200/Jco.2013.31.15_Suppl.2044  0.407
2013 Haas-Kogan D, Phillips JJ, Molinaro A, Wahl M, Mueller S, Weiss WA, Lupo JM, Berger MS, Prados MD, Butowski N, Clarke J, Perry A, Nelson SJ, Chang S. Abstract 3520: Imaging parameters and molecular correlates as predictive markers of treatment response to mTOR inhibition in adults with recurrent low-grade gliomas. Cancer Research. 73: 3520-3520. DOI: 10.1158/1538-7445.Am2013-3520  0.439
2012 Lupo JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ. 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. International Journal of Radiation Oncology, Biology, Physics. 82: e493-500. PMID 22000750 DOI: 10.1016/J.Ijrobp.2011.05.046  0.465
2011 Lupo JM, Li Y, Hess CP, Nelson SJ. Advances in ultra-high field MRI for the clinical management of patients with brain tumors. Current Opinion in Neurology. 24: 605-15. PMID 22045220 DOI: 10.1097/Wco.0B013E32834Cd495  0.404
2011 Li Y, Lupo JM, Polley MY, Crane JC, Bian W, Cha S, Chang S, Nelson SJ. Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro-Oncology. 13: 546-57. PMID 21297128 DOI: 10.1093/Neuonc/Noq194  0.638
2011 Tropp J, Lupo JM, Chen A, Calderon P, McCune D, Grafendorfer T, Ozturk-Isik E, Larson PE, Hu S, Yen YF, Robb F, Bok R, Schulte R, Xu D, Hurd R, et al. Multi-channel metabolic imaging, with SENSE reconstruction, of hyperpolarized [1-(13)C] pyruvate in a live rat at 3.0 tesla on a clinical MR scanner. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 208: 171-7. PMID 21130012 DOI: 10.1016/J.Jmr.2010.10.007  0.367
2011 Essock-Burns E, Lupo JM, Cha S, Polley MY, Butowski NA, Chang SM, Nelson SJ. Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma. Neuro-Oncology. 13: 119-31. PMID 21036812 DOI: 10.1093/Neuonc/Noq143  0.76
2011 Wahl M, Williams CK, Lupo JM, Haas-Kogan D, Nelson SJ. Abstract B110: Early radiographic and physiologic changes in patients with recurrent low-grade gliomas treated with everolimus under a phase II clinical trial. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B110  0.493
2011 Anwar M, Lupo J, Essock-Burns E, Chang S, Nelson S, HaasKogan D. Characteristics of Recurrence in Glioblastoma Treated with Radiation and Anti-angiogenic Therapy using Integrated Dosimetry, Diffusion, Perfusion, and Spectra International Journal of Radiation Oncology*Biology*Physics. 81: S181. DOI: 10.1016/J.Ijrobp.2011.06.321  0.739
2010 Lupo JM, Chen AP, Zierhut ML, Bok RA, Cunningham CH, Kurhanewicz J, Vigneron DB, Nelson SJ. Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Magnetic Resonance Imaging. 28: 153-62. PMID 19695815 DOI: 10.1016/J.Mri.2009.07.007  0.726
2010 LI Y, Lupo JM, Polley MC, Crane JC, Bian W, Cha S, Chang SM, Nelson SJ. Longitudinal analysis of physiologic MRI parameters in patients with newly diagnosed glioblastoma multiforme to predict outcome. Journal of Clinical Oncology. 28: 2078-2078. DOI: 10.1200/Jco.2010.28.15_Suppl.2078  0.483
2009 Bian W, Khayal IS, Lupo JM, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Translational Oncology. 2: 271-80. PMID 19956389 DOI: 10.1593/Tlo.09178  0.781
2009 Lupo JM, Banerjee S, Hammond KE, Kelley DA, Xu D, Chang SM, Vigneron DB, Majumdar S, Nelson SJ. GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magnetic Resonance Imaging. 27: 480-8. PMID 18823730 DOI: 10.1016/J.Mri.2008.08.003  0.445
2008 Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, Vigneron DB. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 193: 139-46. PMID 18424203 DOI: 10.1016/J.Jmr.2008.03.012  0.347
2008 Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage. 39: 1682-92. PMID 18096412 DOI: 10.1016/J.Neuroimage.2007.10.037  0.415
2007 Lupo JM, Cha S, Chang SM, Nelson SJ. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. Ajnr. American Journal of Neuroradiology. 28: 1455-61. PMID 17846190 DOI: 10.3174/Ajnr.A0586  0.435
2007 Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Ajnr. American Journal of Neuroradiology. 28: 1078-84. PMID 17569962 DOI: 10.3174/Ajnr.A0484  0.435
2006 Lupo JM, Lee MC, Han ET, Cha S, Chang SM, Berger MS, Nelson SJ. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction. Journal of Magnetic Resonance Imaging : Jmri. 24: 520-9. PMID 16888776 DOI: 10.1002/Jmri.20673  0.349
2005 Lupo JM, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. Ajnr. American Journal of Neuroradiology. 26: 1446-54. PMID 15956514  0.359
2005 Pirzkall A, Ozturk E, Lee M, Lupo J, Crawford F, Chuang C, Nelson S. Assessing Tumor Response in GBM Following Concurrent Radiation and Chemotherapy by Means of Novel MR Based Imaging Methods Characterizing Metabolic and Physiologic Changes International Journal of Radiation Oncology*Biology*Physics. 63: S66-S67. DOI: 10.1016/J.Ijrobp.2005.07.115  0.432
Show low-probability matches.